| Dr Roger Dale Stanmore, MD | |
|
7583 Wall Triana Hwy, Madison, AL 35757-8327 | |
| (256) 547-6119 | |
| (256) 546-2981 |
| Full Name | Dr Roger Dale Stanmore |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 40 Years |
| Location | 7583 Wall Triana Hwy, Madison, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295772986 | NPI | - | NPPES |
| 51532050 | Other | AL | BLUE CROSS BLUE SHIELD |
| 009932569 | Medicaid | AL | |
| 3015 | Other | AL | NEIC SITE ID |
| 51001283 | Other | AL | BLUE CROSS BLUE SHIELD |
| 3002 | Other | AL | NEIC SITE ID, NSF BA0-7 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 00013106 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington County Hospital | Chatom, AL | Hospital |
| Grove Hill Memorial Hospital | Grove hill, AL | Hospital |
| D W Mcmillan Memorial Hospital | Brewton, AL | Hospital |
| Atmore Community Hospital | Atmore, AL | Hospital |
| Russellville Hospital | Russellville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ess Of Luverne Llc | 0345653622 | 9 |
| Ihp Al Er Pllc | 5395116586 | 7 |
| Correct Care, Inc. | 8628980992 | 68 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | American Family Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429080 PECOS PAC ID: 9739087818 Enrollment ID: O20031229000157 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20040615000906 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Rush Hospital/butler, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811268592 PECOS PAC ID: 0244498368 Enrollment ID: O20120605000787 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20130909000458 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Pickens County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093069569 PECOS PAC ID: 3678708427 Enrollment ID: O20140109001299 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Nwmc Winfield Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366831380 PECOS PAC ID: 8921324393 Enrollment ID: O20150302000951 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Lakeland Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851780951 PECOS PAC ID: 0446578298 Enrollment ID: O20150408000559 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Alabama Post-acute Medical Service 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073052403 PECOS PAC ID: 7416229406 Enrollment ID: O20170825002379 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Nm Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366928749 PECOS PAC ID: 3375892060 Enrollment ID: O20191109000048 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Ess Of Luverne Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457953473 PECOS PAC ID: 0345653622 Enrollment ID: O20210105001927 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Premier Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821671041 PECOS PAC ID: 3971904491 Enrollment ID: O20210622001335 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Ihp Al Er Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568187359 PECOS PAC ID: 5395116586 Enrollment ID: O20230126001106 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Wh Services Brewton Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194408005 PECOS PAC ID: 0648625392 Enrollment ID: O20231016001956 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Entity Name | Wh Services Atmore Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972375574 PECOS PAC ID: 5991154445 Enrollment ID: O20231211000539 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roger Dale Stanmore, MD Po Box 303, Gadsden, AL 35902-0303 Ph: (256) 547-6119 | Dr Roger Dale Stanmore, MD 7583 Wall Triana Hwy, Madison, AL 35757-8327 Ph: (256) 547-6119 |
News Archive
Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.
The mosquitoes known as Aedes aegypti and Aedes albopictus transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses.
Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.
› Verified 9 days ago
Kealan O'neill, D.O. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 104 Spenryn Dr, Madison, AL 35758 Phone: 256-772-4300 Fax: 256-772-4302 | |
Samuel Waling, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Slaughter Rd Ste A, Madison, AL 35758 Phone: 256-325-3646 Fax: 256-325-3647 | |
Deborah Booher Kolb, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8371 Highway 72 W, Suite 200, Madison, AL 35758 Phone: 256-722-0664 Fax: 256-722-0285 | |
Leelasri Vanguru, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Hughes Rd Ste 10, Madison, AL 35758 Phone: 256-464-2920 Fax: 256-542-3200 | |
Mrs. Valerie Levick Wright, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Slaughter Rd Ste A, Madison, AL 35758 Phone: 256-325-3646 Fax: 256-325-3647 | |
Dr. Caswall C Harrigan Sr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8045 Highway 72 W, Suite 100, Madison, AL 35758 Phone: 256-837-2271 Fax: 256-837-2910 | |
David W Purner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12205 County Line Rd, Suite B, Madison, AL 35758 Phone: 256-325-4365 Fax: 256-461-0393 |